Search
for
Sort by
Research 421–450 of 1000+
- TOC
- Cutaneous manifestations of systemic infection in children
- Cutaneous signals of immune system disease
- Abstracts from the Symposium on the Pathophysiology of Hair Growth Organized by the Institute of Dermatology at the Royal Society of Medicine, 29 October 1987
- Westwood Carolina Conference on Clinical Dermatology
- Scalp involvement in pemphigus: a prognostic marker
- Theoretical considerations in laser hair removal
- Molecular basis of hypohidrotic ectodermal dysplasia: an update
- Seasonality of Hair Shedding in Healthy Women Complaining of Hair Loss
- Review paper The use of reflectance confocal microscopy in selected inflammatory skin diseases
- Hair Follicle Reconstruction and Stem Cells
- Health Utility of Facial Angiofibroma associated with Tuberous Sclerosis Complex
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- Erythema multiforme in a Central American tapir (Tapirus bairdii) calf, clinical case report
- A Review on Nanoparticle Based Herbal Remedies for the Management of Alopecia
- A study of cutaneous manifestations of systemic lupus erythematosus in Malwa region of India
- Contents
- Historical Archives
- Inefficiency of ethanolic extract of Glycyrrhiza glabra and Ziziphus mauritiana roots on androgenic alopecia
- A position effect on TRPS1 is associated with Ambras syndrome in humans and the Koala phenotype in mice
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Thyroid hormone action on skin.
- Structure and Function of the Skin
- Cutaneous drug reactions
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Dermatological manifestations of Coronavirus Disease 2019 (COVID-19)
- Contents
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation